Filip Van Nieuwerburgh
ORCID: 0000-0001-8815-5485Also affiliated with Ghent University, Cancer Research Institute Ghent, Pharmaceutical Biotechnology (Czechia)
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 5 papers. Top paper: “RUNX2 regulates leukemic cell metabolism and chemotaxis in high-risk T cell acute lymphoblastic leukemia”.
Nitesh Sharma, Monique Nysus, Christian K. Nickl, Huining Kang, Dominique Perez +32 more
Dieter De Coninck, Christodoulos Christodoulou, Tom Sante, Annelies Dheedene, Björn Heindryckx +6 more
Lisa Depestel, Liselot Mus, Kaylee M. Keller, Louis Delhaye, Amber Louwagie +37 more
Noah Bonine, Rita Verstraeten, Marion Pardons, Ytse Noppe, Sofie Rutsaert +5 more
Noah Bonine, Rita Verstraeten, Marion Pardons, Ytse Noppe, Sofie Rutsaert +5 more